Project Grant H8E38345

This Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program, CFDA 93.323, provides $256,291.00 to the Association of Public Health Laboratories, Inc. (APHL) from July 1, 2025 to June 30, 2030 to enhance public health laboratory capabilities and capacities. The ELC program aims to strengthen epidemiological surveillance, laboratory testing, health information systems, and cross-disciplinary...

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

DPX Technologies LLC received a $254,536 Project Grant award from the National Science Foundation to develop high-throughput COVID-19 testing under the SBIR PHASE I program. The award, provided by NSF's Directorate for Engineering between April 1, 2021 and September 30, 2021, aims to foster innovation in engineering research and development under the Engineering (47.041) federal grant program. Specifically, DPX Technologies will leverage the funding to create products and services focused on...

This federal Cooperative Agreement award was provided by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program. The $2,679,110 award to the Florida Department of Health (FDOH) supports activities to rapidly respond to a significant public health emergency involving a highly infectious disease known as "Disease X" that is expected to...

Cellbae Inc. received a $174,992 Small Business Innovation Research Project Grant from the US Department of Agriculture National Institute of Food and Agriculture to develop rapid test kits for the detection of Escherichia coli O157:H7 and Salmonella enterica. The goal of the six-month project beginning July 1, 2023 is to verify the sensitivity and specificity of Cellbae's rapid test kit platform, which uses enzymatic amplification to increase detection sensitivity over conventional methods....

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program provides $1,499,856.00 to the University of Rochester to implement a project titled "Trusted School Messengers Promoting Non-Mandated Vaccination." The project aims to enhance public health agencies' capacity to detect, respond to, prevent, and control known and emerging infectious diseases through...

This $1,062,500 Cooperative Agreement award from the National Science Foundation's Biological Sciences (CFDA 47.074) program supports the "Pandemic Environmental Surveillance Center for Assessing Pathogen Emergence (Pandemic ESCAPE)" project. The primary goals are to: 1) Advance environmental surveillance (ES) technology, data interpretation, and adoption to enable widespread deployment across the U.S.; 2) Train the next generation of ES scientists; 3) Accelerate ES adoption as a...

The Centers for Disease Control and Prevention (CDC) awarded a $7,018,665 Cooperative Agreement under CFDA 93.354 "Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response" to the Connecticut Department of Public Health (DPH). The funding will be used for crisis planning and active response to highly infectious diseases or other disasters that result in large-scale public health emergencies in Connecticut. Specifically, the DPH...